Literature DB >> 23947089

Severe gynecologic sequelae of Stevens-Johnson syndrome and toxic epidermal necrolysis caused by ibuprofen: a case report.

Steven Pliskow1.   

Abstract

BACKGROUND: Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a serious, drug-induced, life-threatening condition characterized by an epidermal blistering rash with necrosis, desquamation and mucosal surface involvement. This patient represents the youngest and most significant case report in the literature of gynecologic damage due to TEN. CASE: A 31/2-year-old girl developed TEN involving 90% of her body surface area after exposure to pediatric ibuprofen. After onset of puberty she required surgery to treat vulvar, vaginal and cervical adhesions, stenosis and hematometra.
CONCLUSION: While delaying evaluation and treatment of the extremely young child with this disorder until puberty has been the standard, consideration should be given to earlier evaluation and intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23947089

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Vaginal Reconstruction for Vaginal Obliteration Secondary to Stevens Johnson Syndrome: A Case Report and Review of Literature.

Authors:  Gokhan Boyraz; Derman Basaran; M Coskun Salman; Nejat Ozgul; Kunter Yuce
Journal:  Oman Med J       Date:  2017-09

2.  Urogynecologic complications in Stevens-Johnson syndrome and toxic epidermal necrolysis: Presentation of a case and recommendations for management.

Authors:  Tatyana A Petukhova; Emanual Maverakis; Baran Ho; Victoria R Sharon
Journal:  JAAD Case Rep       Date:  2016-05-25

3.  Disease severity and status in Stevens-Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs.

Authors:  Rannakoe J Lehloenya
Journal:  Front Med (Lausanne)       Date:  2022-09-12

4.  Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women.

Authors:  Lauren Knight; Gail Todd; Rudzani Muloiwa; Mushi Matjila; Rannakoe J Lehloenya
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.